Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MYCN copy number and hyperdiploidy: do they define a favourable prognostic group in neuroblastoma patients between 12 and 24 months of age? A COG study

MYCN copy number and hyperdiploidy: do they define a favourable prognostic group in neuroblastoma patients between 12 and 24 months of age? A COG study. Advances in Neuroblastoma Research. 2002; (Paris ).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.